Oct 13, 2026 | Life Sciences
BOSTON, MA, OCTOBER 13, 2026 — SOUFFLÉ THERAPEUTICS, INC. (“Souffle™” or “Company”), a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives, today announced the close of an oversubscribed $135...
Oct 2, 2026 | Life Sciences
In 2017, a man named Michael walked onto stage in front of a packed Kresge Auditorium at MIT and attempted to draw a spiral, a common test doctors use to diagnose Parkinson’s disease. His tremors, caused by the disease, made the exercise difficult. Then, Michael put...
Sep 16, 2026 | Life Sciences
BOSTON, September 15, 2026–(BUSINESS WIRE)–Syntis Bio, Inc., a clinical-stage biopharmaceutical company advancing novel oral therapeutics that uniquely leverage the small intestine, today announced results from its 28-day multiple ascending dose (MAD)...
May 12, 2026 | Life Sciences
BOSTON, May 7, 2026 /PRNewswire/ — Embr Labs, the leader in digital thermal health technology, announced three milestones that underscore its position at the forefront of wearable thermal technology. Marked by clinical validation from Stanford University, a...
May 1, 2026 | Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axoft, a neurotechnology company, today announced it has raised an oversubscribed $55 million Series A led by C.P. Group Innovation. Alumni Ventures, the Stanford President’s Venture Fund, Hillhouse Investment and Gaorong...
May 1, 2026 | Life Sciences
ROCHESTER, N.Y., April 29, 2026 /PRNewswire-PRWeb/ — Clerio Vision, Inc., a developer of next-generation laser-based vision correction platforms, announced that its research team will present data at the 2026 Association for Research in Vision and Ophthalmology...
